Navigation Links
Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
Date:2/20/2008

14,407 12,109 53,722 47,802

Marketing, selling and

general and administrative 11,696 10,771 44,801 40,627

Research and development 1,965 1,321 5,658 4,828

13,661 12,092 50,459 45,455

Operating income 746 17 3,263 2,347

Interest expense, net (129) (176) (588) (914)

Other 185 57 (1) 416

Income (loss) before income

taxes 802 (102) 2,674 1,849

Income tax provision (benefit) (4) (163) 57 (58)

Net Income $ 806 $ 61 $ 2,617 $ 1,907

Earnings per share:

Basic $ .05 $ - $ .15 $ .11

Diluted $ .04 $ - $ .15 $ .11

Shares used in computing

earnings per share:

Basic 17,666,940 17,347,880 17,538,254 17,298,352

Diluted 18,093,058 17,542,228 17,926,384 17,399,719

CONSOLIDATED SEGMENT REVENUE DETAIL

(dollars in thousands)

Three Months Year Ended

Ended December 31, December 31,

2007 2006 2007 2006

DBM $ 17,107 $ 14,792 $ 65,794 $ 57,493

Hybrid/Synthetic 591 332 1,760 1,270

Core Revenue 17,698 15,124 67,554 58,763

Traditional Tissue 4,491 4,674 17,623 16,955

Spinal Allografts 2,438 3,027 10,739 13,795

Client Services 2,085
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
2. Osteotech to Present at Sidoti Conference in San Francisco
3. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
4. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
5. Amsterdam Molecular Therapeutics Reports Full Year Results 2007
6. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
7. United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
8. Favrille Reports Fourth Quarter and Year End 2007 Financial Results
9. JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
10. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
11. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015 US-Australian drug discovery company, Novogen ... it is committed to progressing its ground-breaking technology platforms ... and to ensure the Company delivers the best value ... Iain Ross , said the Company currently had an ... programs, discovery programs and academic partnerships and initiatives, and ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... the Company,s Chief Financial Officer has resigned.  The Company ... Financial Officer who retired in December 2014, as full ... a permanent successor.     Andy Ashworth ... and ensure a smooth transition.  Andy was the Company,s ...
(Date:7/29/2015)... , July 29, 2015  AsureQuality and Ubiquitome ... testing for applications in food and primary production ... powered real-time PCR device, the Freedom4. ... through to the supermarket shelf for producers, processors ... involvement in animal disease control and pest management ...
(Date:7/29/2015)... , July 29, 2015 ... announced the addition of the "Global Biosimilars ... offering. The Global Biosimilars Market, 2015 ... the rapidly growing biosimilars market. With the blockbuster ... to minimize costs, biosimilars are being viewed as ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3
... - The Center for International Blood and Marrow ... has won a contract worth $6,180,029 to collect and ... transplants that use cells from bone marrow or cord blood. ... of the U.S. Department of Health and Human Services ...
... Wisconsin is a donor state. There's no oil, natural gas, ... dollars leave Wisconsin every day to buy energy from the ... , ,Wisconsin's donor-state status isn't going to change soon, despite ... conserve. While part of the answer, conservation alone will not ...
... ticking on the 18-month window for Midwest Fiber Networks ... service. , ,After months of indecision and the courting of ... Cellnet , Mayor Tom Barrett decided to sign a contract ... build a $20 million "Wi-Fi" network, starting with a demonstration ...
Cached Biology Technology:Medical College to build $6M transplant database 2State should keep open mind on nuclear power 2State should keep open mind on nuclear power 3State should keep open mind on nuclear power 4Milwaukee could be wireless in 18 months 2
(Date:6/25/2015)... N.J. , June 25, 2015  TAKE Solutions ... a patent by the United States Patent and Trademark ... Standardization". This process leverages TAKE Solutions, Clinical Accelerators to ... over 50% (when compared to standardization without the accelerators), ... At the heart of ...
(Date:6/24/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that Sharp has selected its industry-leading Natural ... its latest flagship smartphone device, the AQUOS ZETA ... shipments of its fingerprint ID sensor technology, this ... and leadership in the biometrics market through its ...
(Date:6/23/2015)... 23, 2015   MedNet Solutions , an ... entire spectrum of clinical research, is pleased to ... , the company,s intuitive, flexible and affordable cloud-based ... 2015 Stevie® Award by the American Business ... Website category.  The American Business Awards are considered ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... potentially ground-breaking treatment for nerve damage caused by diabetes ... trials. , The University of Manchester team has discovered ... stimulating a person's genes may prevent nerve damage ?primarily ... , The positive preclinical results ?reported in the journal ...
... that allows breast cancer cells to evade the body's natural immune ... a study by scientists from the Keck School of Medicine of ... the July 1 issue of the American Journal of Pathology, is ... the surface of cells ?functions. , "The important aspect of ...
... the genetic controls which cause trees to stop growing ... the mechanism that causes them to begin flowering and ... basic genetics of tree growth. , The findings were ... Sciences, Oregon State University and two other institutions, and ...
Cached Biology News:Trial success for diabetic nerve therapy 2USC researchers investigate protein that protects tumors 2Discovery may speed forest biotechnology 2Discovery may speed forest biotechnology 3
... Fast DNA Modification Kit contains reagents required ... DNA sample. In the bisulfite reaction, all ... them to uracils, while 5-methylcytosines remain unaltered. ... will differ depending on whether the DNA ...
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
...
... GELase™ Agarose Gel-Digesting Preparation contains a ... for simple, quantitative recovery of intact DNA ... agarose gels following electrophoresis in TAE, TBE, ... be digested directly in the TAE, TBE, ...
Biology Products: